Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

753 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial.
Di Lorenzo G, Ingenito C, D'Ambrosio B, Ranieri C, Iuliucci MR, Iervolino M, Primiano F, Buonerba L, Busto G, Ferrara C, Libroia A, Ragone G, De Falco F, Costabile F, Fimiani P, Ugliano F, Leo E, Roviello G, Scafuri L, Buonerba C. Di Lorenzo G, et al. Oncology. 2022;100(9):512-518. doi: 10.1159/000525962. Epub 2022 Jul 11. Oncology. 2022. PMID: 35817009 Free article.
A comprehensive outlook on intracerebral therapy of malignant gliomas.
Buonerba C, Di Lorenzo G, Marinelli A, Federico P, Palmieri G, Imbimbo M, Conti P, Peluso G, De Placido S, Sampson JH. Buonerba C, et al. Among authors: di lorenzo g. Crit Rev Oncol Hematol. 2011 Oct;80(1):54-68. doi: 10.1016/j.critrevonc.2010.09.001. Epub 2010 Oct 2. Crit Rev Oncol Hematol. 2011. PMID: 20888252 Review.
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients.
Buonerba C, Federico P, D'Aniello C, Rescigno P, Cavaliere C, Puglia L, Ferro M, Altieri V, Perdonà S, De Placido S, Di Lorenzo G. Buonerba C, et al. Among authors: di lorenzo g. Cancer Chemother Pharmacol. 2011 Jun;67(6):1455-61. doi: 10.1007/s00280-011-1594-z. Epub 2011 Mar 2. Cancer Chemother Pharmacol. 2011. PMID: 21365219 Clinical Trial.
Immunotherapy for the treatment of prostate cancer.
Di Lorenzo G, Buonerba C, Kantoff PW. Di Lorenzo G, et al. Nat Rev Clin Oncol. 2011 May 24;8(9):551-61. doi: 10.1038/nrclinonc.2011.72. Nat Rev Clin Oncol. 2011. PMID: 21606971 Review.
753 results